These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28724388)

  • 1. O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson's disease.
    Wani WY; Ouyang X; Benavides GA; Redmann M; Cofield SS; Shacka JJ; Chatham JC; Darley-Usmar V; Zhang J
    Mol Brain; 2017 Jul; 10(1):32. PubMed ID: 28724388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrils.
    Tavassoly O; Yue J; Vocadlo DJ
    FEBS J; 2021 Jan; 288(2):452-470. PubMed ID: 32365408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus.
    Heath JM; Sun Y; Yuan K; Bradley WE; Litovsky S; Dell'Italia LJ; Chatham JC; Wu H; Chen Y
    Circ Res; 2014 Mar; 114(7):1094-102. PubMed ID: 24526702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation.
    Yu Y; Zhang L; Li X; Run X; Liang Z; Li Y; Liu Y; Lee MH; Grundke-Iqbal I; Iqbal K; Vocadlo DJ; Liu F; Gong CX
    PLoS One; 2012; 7(4):e35277. PubMed ID: 22536363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells.
    Jin L; Yuan F; Dai G; Yao Q; Xiang H; Wang L; Xue B; Shan Y; Liu X
    Cell Mol Biol Lett; 2020; 25():17. PubMed ID: 32174982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease.
    Marotta NP; Lin YH; Lewis YE; Ambroso MR; Zaro BW; Roth MT; Arnold DB; Langen R; Pratt MR
    Nat Chem; 2015 Nov; 7(11):913-20. PubMed ID: 26492012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.
    Levine PM; Galesic A; Balana AT; Mahul-Mellier AL; Navarro MX; De Leon CA; Lashuel HA; Pratt MR
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1511-1519. PubMed ID: 30651314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Inhibition of O-GlcNAcase Enhances Autophagy in Brain through an mTOR-Independent Pathway.
    Zhu Y; Shan X; Safarpour F; Erro Go N; Li N; Shan A; Huang MC; Deen M; Holicek V; Ashmus R; Madden Z; Gorski S; Silverman MA; Vocadlo DJ
    ACS Chem Neurosci; 2018 Jun; 9(6):1366-1379. PubMed ID: 29460617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAcylation of light chain serine 12 mediates rituximab production doubled by thiamet G.
    Kim HY; Park M; Kang C; Heo W; Yoon SM; Lee J; Kim JY
    Bioprocess Biosyst Eng; 2020 May; 43(5):863-875. PubMed ID: 31980903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.
    Sánchez RG; Parrish RR; Rich M; Webb WM; Lockhart RM; Nakao K; Ianov L; Buckingham SC; Broadwater DR; Jenkins A; de Lanerolle NC; Cunningham M; Eid T; Riley K; Lubin FD
    Neurobiol Dis; 2019 Apr; 124():531-543. PubMed ID: 30625365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAc modification inhibits the calpain-mediated cleavage of α-synuclein.
    Levine PM; De Leon CA; Galesic A; Balana A; Marotta NP; Lewis YE; Pratt MR
    Bioorg Med Chem; 2017 Sep; 25(18):4977-4982. PubMed ID: 28487126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of O-GlcNAcylation Regulates Autophagy in Cortical Astrocytes.
    Rahman MA; Hwang H; Cho Y; Rhim H
    Oxid Med Cell Longev; 2019; 2019():6279313. PubMed ID: 31827688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
    Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycerol-3-phosphate acyltransferase-1 upregulation by O-GlcNAcylation of Sp1 protects against hypoxia-induced mouse embryonic stem cell apoptosis via mTOR activation.
    Lee HJ; Ryu JM; Jung YH; Lee KH; Kim DI; Han HJ
    Cell Death Dis; 2016 Mar; 7(3):e2158. PubMed ID: 27010859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies.
    Permanne B; Sand A; Ousson S; Nény M; Hantson J; Schubert R; Wiessner C; Quattropani A; Beher D
    ACS Chem Neurosci; 2022 Apr; 13(8):1296-1314. PubMed ID: 35357812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease.
    Xu Y; Liu C; Chen S; Ye Y; Guo M; Ren Q; Liu L; Zhang H; Xu C; Zhou Q; Huang S; Chen L
    Cell Signal; 2014 Aug; 26(8):1680-1689. PubMed ID: 24726895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.
    Groves JA; Lee A; Yildirir G; Zachara NE
    Cell Stress Chaperones; 2013 Sep; 18(5):535-58. PubMed ID: 23620203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAcylation modulates HBV replication through regulating cellular autophagy at multiple levels.
    Wang X; Lin Y; Liu S; Zhu Y; Lu K; Broering R; Lu M
    FASEB J; 2020 Nov; 34(11):14473-14489. PubMed ID: 32892442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.